1. E3 ubiquitin ligase UBR5 promotes pancreatic cancer growth and aerobic glycolysis by downregulating FBP1 via destabilization of C/EBPα
   Leifeng Chen et al, 2021, Oncogene CrossRef
2. YY1 and noncoding RNAs: A two-way relationship
   Silvia Vivarelli et al, 2021, YY1 in the Control of the Pathogenesis and Drug Resistance of Cancer CrossRef
3. MicroRNAs in the Pathogenesis of Renal Cell Carcinoma and Their Diagnostic and Prognostic Utility as Cancer Biomarkers
   Michal Fedorko et al, 2016, The International Journal of Biological Markers CrossRef
4. Accumulation of p53 via down-regulation of UBE2D family genes is a critical pathway for cadmium-induced renal toxicity
   Jin-Yong Lee et al, 2016, Scientific Reports CrossRef
5. Participation of different miRNAs in the regulation of YY1: Their role in pathogenesis, chemoresistance, and therapeutic implication in hematologic malignancies
   Mario Morales-Martinez et al, 2021, YY1 in the Control of the Pathogenesis and Drug Resistance of Cancer CrossRef
6. Prognostic significance of YY1 protein expression and mRNA levels by bioinformatics analysis in human cancers: A therapeutic target
   Benjamin Bonavida et al, 2015, Pharmacology & Therapeutics CrossRef
7. YY1 regulates cancer cell immune resistance by modulating PD-L1 expression
   Emily Hays et al, 2019, Drug Resistance Updates CrossRef
8. Expression of YY1 in Wilms tumors with favorable histology is a risk factor for adverse outcomes
   Marta Zapata-Tarres et al, 2019, Future Oncology CrossRef
9. MicroRNAs and JAK/STAT3 signaling: A new promising therapeutic axis in blood cancers
   Mehdi Sajjadi-Dokht et al, 2022, Genes & Diseases CrossRef
10. MiR-34a regulates the glucose metabolism of Blunt snout bream (Megalobrama amblycephala) fed high-carbohydrate diets through the mediation of the Sirt1/FoxO1 axis
    Ling-Hong Miao et al, 2019, Aquaculture CrossRef
11. Dual biomarkers long non-coding RNA GAS5 and microRNA-34a co-expression signature in common solid tumors
    Eman A. Toraih et al, 2018, PLOS ONE CrossRef
12. YY1 regulates melanoma tumorigenesis through a miR-9 ~ RYBP axis
    Guowei Zhao et al, 2015, Journal of Experimental & Clinical Cancer Research CrossRef
13. Integrative genomic analyses of the RNA-binding protein, RNPC1, and its potential role in cancer prediction
    ZHIMING DING et al, 2015, International Journal of Molecular Medicine CrossRef
14. A network-biology perspective of microRNA function and dysfunction in cancer
    Cameron P. Bracken et al, 2016, Nature Reviews Genetics CrossRef
15. Upregulation of miR-146a by YY1 depletion correlates with delayed progression of prostate cancer
    Yeqing Huang et al, 2017, International Journal of Oncology CrossRef
16. Original Research: Stable expression of miR-34a mediates fetal hemoglobin induction in K562 cells
    Christina M Ward et al, 2016, Experimental Biology and Medicine CrossRef
17. Methylation of miRNA genes and oncogenesis
    V. I. Loginov et al, 2015, Biochemistry (Moscow) CrossRef
18. Epigenetic regulators: Polycomb-miRNA circuits in cancer
    Filomena de Nigris, 2016, Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms CrossRef
19. Inverse correlation between the metastasis suppressor RKIP and the metastasis inducer YY1: Contrasting roles in the regulation of chemo/immuno-resistance in cancer
    Stephanie Wottrich et al, 2017, Drug Resistance Updates CrossRef
20. Epigenetics in renal cell cancer: mechanisms and clinical applications
    Sophie C. Joosten et al, 2018, Nature Reviews Urology CrossRef